Delivery Order SPE2DB24D1104-SPE2DB25FXUL4

Award Date 11/12/24
Potential Completion Date 12/4/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,484.30 firm fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,740.00 firm fixed-price delivery order contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, with a performance period ending on February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,740.00 Firm Fixed Price Delivery Order covers the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,740.00 Firm Fixed Price Delivery Order is for the provision of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of April 1, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,242.15, is for the delivery of the drug BRUKINSA 80 MG CAPSULE 120S. This is a firm fixed-price delivery order contract with a completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,984.88 firm fixed-price delivery order contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,740.00 firm fixed price delivery order contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,740.00 Firm Fixed Price Delivery Order contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $12,740.00, is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,492.44 firm fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a performance period through December 30, 2024. This contract is not designated as a set-aside and represents open competition. AmerisourceBergen Drug Corp also holds a $999,999,999.00...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FXUL4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,484.30 Firm Fixed Price Delivery Order contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, with a period of performance through December 4, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This contract award did not utilize any set-aside designations, indicating open competition.

Generated 2/11/25, 10:31 AM